• by: k
  • recipient: k


To the Australian Therapeutic Goods Administration and the Australian Minister for Health Tanya Plibersek,

The Australian Therapeutic Goods Administration has refused to register Human Genome Sciences and GlaxoSmithKline's Benlysta® for use in Australia.

Benlysta® is the first medication developed specifically to treat patients with lupus. Unless it is registered doctors and patients will not have access to all the available treatment options.

Sign Petition
Sign Petition
You have JavaScript disabled. Without it, our site might not function properly.

Privacy Policy

By signing, you accept Care2's Terms of Service.
You can unsub at any time here.

Having problems signing this? Let us know.